| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
13,439 |
11,877 |
$484K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
4,917 |
4,511 |
$303K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
15,361 |
13,669 |
$295K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
1,756 |
1,484 |
$186K |
| 80053 |
Comprehensive metabolic panel |
2,063 |
1,811 |
$144K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
2,607 |
2,360 |
$119K |
| 36415 |
Collection of venous blood by venipuncture |
6,592 |
5,671 |
$103K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
5,204 |
4,496 |
$72K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
294 |
250 |
$68K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
4,692 |
3,462 |
$59K |
| S0302 |
Completed early periodic screening diagnosis and treatment (epsdt) service (list in addition to code for appropriate evaluation and management service) |
2,862 |
2,797 |
$54K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
331 |
320 |
$45K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
732 |
709 |
$39K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
983 |
949 |
$35K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
433 |
416 |
$29K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
608 |
493 |
$25K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
597 |
582 |
$24K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
460 |
422 |
$23K |
| 85027 |
|
417 |
398 |
$21K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
313 |
295 |
$20K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
717 |
666 |
$18K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
1,268 |
1,204 |
$14K |
| 81001 |
|
322 |
304 |
$12K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
147 |
145 |
$10K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
126 |
126 |
$7K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
309 |
300 |
$6K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
143 |
134 |
$5K |
| 87070 |
|
120 |
112 |
$5K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
59 |
49 |
$5K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
87 |
87 |
$5K |
| 84443 |
Thyroid stimulating hormone (TSH) |
101 |
100 |
$4K |
| 0240U |
|
28 |
27 |
$3K |
| 92552 |
|
193 |
189 |
$3K |
| 80061 |
Lipid panel |
28 |
27 |
$2K |
| X5622 |
|
899 |
883 |
$2K |
| 99188 |
|
150 |
144 |
$2K |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
749 |
687 |
$1K |
| 87077 |
|
34 |
30 |
$1K |
| 84439 |
|
29 |
27 |
$1K |
| 83735 |
|
29 |
26 |
$1K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
13 |
12 |
$1K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
13 |
12 |
$1K |
| 82728 |
|
14 |
14 |
$1K |
| 99173 |
|
184 |
182 |
$985.84 |
| 90686 |
|
460 |
449 |
$983.82 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
143 |
71 |
$918.77 |
| 86140 |
|
30 |
28 |
$764.17 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
16 |
14 |
$755.99 |
| 83550 |
|
14 |
14 |
$674.50 |
| 83540 |
|
14 |
14 |
$594.76 |
| J2704 |
Injection, propofol, 10 mg |
17 |
12 |
$571.32 |
| 87510 |
|
18 |
17 |
$432.88 |
| 87480 |
|
18 |
17 |
$432.88 |
| 87660 |
|
18 |
17 |
$432.88 |
| 87081 |
|
15 |
13 |
$299.12 |
| 90670 |
|
37 |
36 |
$287.34 |
| 90656 |
|
61 |
60 |
$284.40 |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
58 |
55 |
$276.69 |
| A9270 |
Non-covered item or service |
40 |
37 |
$0.00 |
| 90633 |
|
15 |
15 |
$0.00 |
| 90671 |
|
12 |
12 |
$0.00 |